The company uses computational design to control the function of RNA for molecular detection and therapeutics. SEATTLE — RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led by Notation Capital and Divergent Capital to continue its groundbreaking work in the use of RNA as a detection and therapeutic platform. RNA […]
SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that Ascendas Genomics has received approval from the National Medical Products Administration (NMPA) of China for use of the company’s Biomark™ family of systems and its Juno™ system in NMPA molecular diagnostics services, enabling […]
Company Also Announces New WFI Quality Water Product to be Made Available Through Online Catalog in November HOLLISTER, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, announced the creation of […]
Collaboration to unify NanoString’s best-in-class spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated end-to-end workflows for translational research studies. SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, today announced a […]
SAN DIEGO, Calif. – Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $40 million in Series A financing led by Deerfield Management Company with participation by Foresite Capital. Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and […]
Novel name reflects expansion of capabilities and solutions SAN DIEGO — Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to Telesis Bio. “Our innovative and pioneering spirit, and the versatility and power of our technologies, have enabled us to expand […]
Larger site will be future home of the Organoid Innovation Center – Salzburg, a collaborative space for advancing automated cell line development, organoid development, and screening solutions to improve drug discovery SAN JOSE, Calif., and SALZBURG, Austria – At a ribbon-cutting ceremony today, Molecular Devices, LLC., a leading provider of high-performance life science solutions, celebrated the completed […]
Company partners with leading distributors in the Gulf region and Israel as well as expands Asia Pacific coverage to Japan for sales, service and support of SYNTAX System instruments and kits SOUTH SAN FRANCISCO, Calif. & PARIS — DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has signed distribution […]
Aims to improve efficiency of pharma pipelines by leveraging industry-leading ability to identify genetic variants that contribute to human disease SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by […]
SEATTLE–TwinStrand Biosciences, Inc. (TwinStrand), the pioneer in Duplex Sequencing technology, which delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology, today announced that the company has implemented a reorganization designed to sustain growth through a focus on key commercial initiatives. As part of this effort, TwinStrand has […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
